Semi-Annual Consolidated Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7335898

Concept 2023-03-01 to
2024-02-29
As at
2024-02-29
As at
2023-02-28
2022-03-01 to
2023-02-28
As at
2022-02-28
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
18,474,000,000 JPY
16,179,000,000 JPY
Interest and dividends received
3,757,000,000 JPY
1,897,000,000 JPY
Interest paid
-18,000,000 JPY
-15,000,000 JPY
Income taxes paid
-4,017,000,000 JPY
-5,333,000,000 JPY
Net cash provided by (used in) operating activities
18,188,000,000 JPY
12,727,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-12,924,000,000 JPY
-7,859,000,000 JPY
Proceeds from sale of property, plant and equipment
186,000,000 JPY
1,004,000,000 JPY
Purchase of investment securities
-15,000,000 JPY
-5,897,000,000 JPY
Proceeds from collection of loans receivable
2,000,000 JPY
2,000,000 JPY
Other, net
25,000,000 JPY
JPY
Net cash provided by (used in) investing activities
-2,512,000,000 JPY
-23,868,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-66,000,000 JPY
-71,000,000 JPY
Purchase of treasury shares
-9,796,000,000 JPY
-7,694,000,000 JPY
Dividends paid
-6,578,000,000 JPY
-6,719,000,000 JPY
Net cash provided by (used in) financing activities
-16,691,000,000 JPY
-14,687,000,000 JPY
Dividends paid to non-controlling interests
-111,000,000 JPY
-61,000,000 JPY
Other, net
-133,000,000 JPY
-140,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,957,000,000 JPY
5,005,000,000 JPY
Net increase (decrease) in cash and cash equivalents
941,000,000 JPY
-20,822,000,000 JPY
Cash and cash equivalents
66,366,000,000 JPY
65,424,000,000 JPY
86,247,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.